The neuronal nicotinic receptor partial agonist ABT 089* appears to be effective for treating adults with attention-deficit hyperactivity disorder
2006 ◽
Vol 59
(11)
◽
pp. 1065-1070
◽
2007 ◽
Vol 74
(8)
◽
pp. 1212-1223
◽
2012 ◽
Vol 73
(06)
◽
pp. 783-789
◽
2014 ◽
Vol 75
(3)
◽
pp. 207-214
◽
2006 ◽
Vol 48
(06)
◽
pp. 483
◽
Assessment of Attention-Deficit/Hyperactivity Disorder: An Evaluation of Six Published Rating Scales
2003 ◽
Vol 32
(2)
◽
pp. 241-262
◽